Developer docs
API playgroundTry for free, no card

Search company profiles

VirHealth

Full company profile

uuid002345e

Namestring
VirHealth
Legal namestring
VIRHEALTH SAS
Websiteurl
virhealth.fr
Company typeenum
Private
Founded yearint
2015
Descriptiontext

VirHealth SAS is a French Contract Research Organization (CRO) headquartered in Lyon that provides specialized antiviral and antimicrobial efficacy testing for the disinfection industry. Operating from a 500 m² facility with both BSL-2 and BSL-3 laboratories, the company serves manufacturers and distributors of PT2, PT3 and PT4 biocide products, healthcare and pharmaceutical organizations, the veterinary and livestock sector, and industrial partners evaluating antimicrobial materials, coatings, surfaces and textiles. The laboratory holds ISO/CEI 17025 accreditation (n°1-7113) from Cofrac, which is the principal quality framework recognized by EU regulatory authorities for biocide efficacy submissions.

The company's service portfolio is organized around five core testing domains — veterinary disinfection (TP3 standards), medical/industrial/institutional disinfection (PT2-TP4), healthcare-industry CRO validation, disinfection equipment testing (steam, UV/ozone, and water systems up to 200 L), and antimicrobial materials and textiles. Proprietary protocols differentiate the offering, including dry inoculum transfer procedures for hydrophobic surfaces, a Quantitative Biological Indicator (QBI) strategy developed since 2020 for worst-case evaluation of automated airborne surface disinfection cycles, surface spill simulation testing, an EN 16615 four-field wipe test, and an egg embryogenesis impact method. Testing capacity spans more than 70 viral strains and more than 50 bacterial, fungal and yeast strains, including antibiotic-resistant organisms, supported by a specialized 79 m³ test chamber for airborne surface disinfection system validation per NF EN 17272.

VirHealth generates revenue through project-based professional services — standardized efficacy tests under FR/EN/ISO norms plus custom protocols — sold on a quote basis directly to enterprise clients via a sales-led motion. The company is privately held under SAS corporate form with €22,080 in share capital, no disclosed external investors, parent or subsidiaries, and is led by Publication Director Vincent Moules. Geographic reach is presently European with the Lyon headquarters, and the company displays public-sector partner recognition from France 2030 and Région Auvergne-Rhône-Alpes.

Short descriptiontext

VirHealth is a Lyon-based French CRO providing ISO/CEI 17025-accredited antiviral and antimicrobial efficacy testing for disinfection product manufacturers, healthcare organizations, veterinary and livestock operators, and antimicrobial materials and textiles producers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLyon, France
HQ citystring
Lyon
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
antiviral efficacy testing, antimicrobial testing services, disinfection validation, contract research laboratory, biocide efficacy testing
Industry2 codes
1Central Laboratory & Clinical Trial Testing CROs
CodeHLAGAAAEPrimaryYes
2Laboratory Quality Systems, Accreditation & Proficiency Testing Programs
CodeHLAJAIAMPrimaryNo
NAICS code1 code
  • Testing Laboratories and Services541380
SIC code2 codes
  • Services-Testing Laboratories8734
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Laboratory Testing Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Research Organization (CRO) Testing Services
TypeProfessional Services
Description

VirHealth provides specialized laboratory testing services for disinfection products, equipment, and technologies. Services include standardized efficacy tests (FR/EN/ISO standards), custom protocols adapted to client-specific needs, and specialized assessments of long-term antimicrobial performance. Revenue is generated through project-based professional services for manufacturers and distributors in the disinfection industry, supporting regulatory market access requirements.

virhealth.fr
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

VirHealth is a specialized Contract Research Organization (CRO) providing antiviral and antimicrobial efficacy testing services for disinfection products, equipment, and technologies. The laboratory operates BSL-2 and BSL-3 facilities in Lyon, France, delivering standardized FR/EN/ISO-compliant efficacy tests, custom protocols, and specialized long-term antimicrobial performance assessments to manufacturers, distributors, and the healthcare and veterinary sectors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 500 m² of BSL-2 and BSL-3 laboratory space
+2 more records
Product overview1 text field

VirHealth is a specialized contract research laboratory providing antiviral and antimicrobial testing services for the disinfection industry. The company operates as a single integrated platform offering four interconnected testing services: Veterinary Domain Testing (TP3) for livestock disinfection products, Medical/Industrial/Institutional Domain Testing (PT2-TP4) for healthcare and pharmaceutical applications, Healthcare Industries CRO Services for pharmaceutical validation, and Disinfection Equipment Testing for steam, UV/ozone, and water systems. Supporting these core services are specialized offerings including Antimicrobial Materials/Textiles Testing with durability assessment, Quantitative Biological Indicator (QBI) development, Swimming Pool/Spa Disinfectant Testing, Hatching Egg Disinfection Testing, Footbath Protocol Testing, and PAS 2424 Residual Efficacy Testing. The company operates 500 m² of BSL-2 and BSL-3 laboratories with a specialized 79 m³ test chamber for airborne surface disinfection, and holds ISO/CEI 17025 accreditation (n°1-7113).

Product and service5 records
1Veterinary Domain Testing (TP3)
CategoryVeterinary Disinfection Testing
2Medical / Industrial / Institutional Domain Testing (PT2-TP4)
CategoryMedical and Institutional Disinfection Testing
3Healthcare Industries CRO Services
CategoryPharmaceutical CRO Services
4Disinfection Equipment Testing
CategoryDisinfection Equipment Validation
5Antimicrobial Materials / Textiles Testing
CategoryAntimicrobial Materials Testing
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
1Analyzair
Strategic tierMinorTypeOthers
Description

Partner organization displayed on VirHealth's website. Nature of partnership not explicitly defined in available source material.

virhealth.fr
Strategic tierMinorTypeOthers
Description

Partner organization displayed on VirHealth's website. Nature of partnership not explicitly defined in available source material.

Strategic tierMinorTypeOthers
Description

Partner organization displayed on VirHealth's website. Nature of partnership not explicitly defined in available source material.

4Izinovation
Strategic tierMinorTypeOthers
Description

Partner organization displayed on VirHealth's website. Nature of partnership not explicitly defined in available source material.

virhealth.fr
Strategic tierMinorTypeOthers
Description

Partner organization displayed on VirHealth's website. Nature of partnership not explicitly defined in available source material.

Strategic tierMinorTypeOthers
Description

Public funding initiative and regional government partnership logo displayed on VirHealth's website, indicating potential public funding or regional support for innovation.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global public health and safety organization providing testing, certification, and standards services including antimicrobial product efficacy and disinfectant validation. Direct overlap on regulatory-grade efficacy testing for biocide manufacturers.

TypeBroad incumbent
Description

Global TIC (testing, inspection, certification) giant with a large life sciences and consumer products testing practice covering antimicrobial efficacy, hygiene, and disinfection product validation across PT2-PT4 categories.

TypeBroad incumbent
Description

Global testing services giant offering microbiological, virological, and disinfection efficacy testing among a massive portfolio. Competes with VirHealth in regulated antimicrobial and biocide testing, especially for large multinational manufacturers.

TypeBroad incumbent
Description

Global TIC incumbent with an extensive microbiological and chemical testing network for consumer products, healthcare, and industrial disinfection. Competes on standardized and custom antimicrobial efficacy protocols.

TypeDirect peer
Description

Specialized microbiological and sterility testing lab serving medical device, pharmaceutical, and consumer products industries. Overlaps with VirHealth on antimicrobial efficacy, sterilization validation, and cleanroom disinfection testing.

TypeOthers
Description

Major French disinfectant manufacturer (now part of Ecolab) that commissions and conducts its own antimicrobial testing. Comparable as a customer/ecosystem peer shaping biocide testing protocols in France.

TypeEmerging player
Description

Specialty provider of microbial detection and ATP hygiene monitoring, including disinfectant efficacy testing. Closely comparable niche focus on rapid and standard microbiological testing of disinfectants and sanitizers.

8Dr. Brill + Partner / Institute for Hygiene and Microbiology
TypeDirect peer
Description

German-based testing institute specializing in disinfectant, antiseptic, and antimicrobial efficacy testing under EN/DVG/VAH standards. Closest continental European peer in standardized biocide testing.

TypeDirect peer
Description

French-based virology and microbiology CRO offering virus stock production, viral clearance, and biosafety testing. Most direct peer to VirHealth in virology-focused CRO services for healthcare and biocide clients.

TypeBroad incumbent
Description

French-headquartered in vitro diagnostics and microbiology leader with industrial microbiology and contract testing services. Adjacent overlap on microbial efficacy and sterility/disinfection testing in pharma and food.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

VirHealth

Contract Research Laboratory Testing Servicesvirhealth.fr

VirHealth is a Lyon-based French CRO providing ISO/CEI 17025-accredited antiviral and antimicrobial efficacy testing for disinfection product manufacturers, healthcare organizations, veterinary and livestock operators, and antimicrobial materials and textiles producers.

What VirHealth does

VirHealth SAS is a French Contract Research Organization (CRO) headquartered in Lyon that provides specialized antiviral and antimicrobial efficacy testing for the disinfection industry. Operating from a 500 m² facility with both BSL-2 and BSL-3 laboratories, the company serves manufacturers and distributors of PT2, PT3 and PT4 biocide products, healthcare and pharmaceutical organizations, the veterinary and livestock sector, and industrial partners evaluating antimicrobial materials, coatings, surfaces and textiles. The laboratory holds ISO/CEI 17025 accreditation (n°1-7113) from Cofrac, which is the principal quality framework recognized by EU regulatory authorities for biocide efficacy submissions.

The company's service portfolio is organized around five core testing domains — veterinary disinfection (TP3 standards), medical/industrial/institutional disinfection (PT2-TP4), healthcare-industry CRO validation, disinfection equipment testing (steam, UV/ozone, and water systems up to 200 L), and antimicrobial materials and textiles. Proprietary protocols differentiate the offering, including dry inoculum transfer procedures for hydrophobic surfaces, a Quantitative Biological Indicator (QBI) strategy developed since 2020 for worst-case evaluation of automated airborne surface disinfection cycles, surface spill simulation testing, an EN 16615 four-field wipe test, and an egg embryogenesis impact method. Testing capacity spans more than 70 viral strains and more than 50 bacterial, fungal and yeast strains, including antibiotic-resistant organisms, supported by a specialized 79 m³ test chamber for airborne surface disinfection system validation per NF EN 17272.

VirHealth generates revenue through project-based professional services — standardized efficacy tests under FR/EN/ISO norms plus custom protocols — sold on a quote basis directly to enterprise clients via a sales-led motion. The company is privately held under SAS corporate form with €22,080 in share capital, no disclosed external investors, parent or subsidiaries, and is led by Publication Director Vincent Moules. Geographic reach is presently European with the Lyon headquarters, and the company displays public-sector partner recognition from France 2030 and Région Auvergne-Rhône-Alpes.

VirHealth firmographics

Firmographics
Name
VirHealth
Legal name
VIRHEALTH SAS
Website
https://virhealth.fr
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
VirHealth is a Lyon-based French CRO providing ISO/CEI 17025-accredited antiviral and antimicrobial efficacy testing for disinfection product manufacturers, healthcare organizations, veterinary and livestock operators, and antimicrobial materials and textiles producers.
Ownership category
akta.pro rank

VirHealth industry classification

Industry
Product category
Contract Research Laboratory Testing Services
NAICS
Testing Laboratories and Services (541380)
SIC
Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)
akta.pro secondary industry
Laboratory Quality Systems, Accreditation & Proficiency Testing Programs (HLAJAIAM)

Keywords

  • Antiviral efficacy testing
  • Antimicrobial testing services
  • Disinfection validation
  • Contract research laboratory
  • Biocide efficacy testing

Where VirHealth is headquartered

Location

Headquarters

HQ city
Lyon
HQ country
France
HQ region
Europe

Offices1 record

Markets served

VirHealth business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Contract Research Organization (CRO) Testing Services: VirHealth provides specialized laboratory testing services for disinfection products, equipment, and technologies. Services include standardized efficacy tests (FR/EN/ISO standards), custom protocols adapted to client-specific needs, and specialized assessments of long-term antimicrobial performance. Revenue is generated through project-based professional services for manufacturers and distributors in the disinfection industry, supporting regulatory market access requirements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

VirHealth product offering

Product offering

Core offering

VirHealth is a specialized Contract Research Organization (CRO) providing antiviral and antimicrobial efficacy testing services for disinfection products, equipment, and technologies. The laboratory operates BSL-2 and BSL-3 facilities in Lyon, France, delivering standardized FR/EN/ISO-compliant efficacy tests, custom protocols, and specialized long-term antimicrobial performance assessments to manufacturers, distributors, and the healthcare and veterinary sectors.

Product overview

VirHealth is a specialized contract research laboratory providing antiviral and antimicrobial testing services for the disinfection industry. The company operates as a single integrated platform offering four interconnected testing services: Veterinary Domain Testing (TP3) for livestock disinfection products, Medical/Industrial/Institutional Domain Testing (PT2-TP4) for healthcare and pharmaceutical applications, Healthcare Industries CRO Services for pharmaceutical validation, and Disinfection Equipment Testing for steam, UV/ozone, and water systems. Supporting these core services are specialized offerings including Antimicrobial Materials/Textiles Testing with durability assessment, Quantitative Biological Indicator (QBI) development, Swimming Pool/Spa Disinfectant Testing, Hatching Egg Disinfection Testing, Footbath Protocol Testing, and PAS 2424 Residual Efficacy Testing. The company operates 500 m² of BSL-2 and BSL-3 laboratories with a specialized 79 m³ test chamber for airborne surface disinfection, and holds ISO/CEI 17025 accreditation (n°1-7113).

Differentiator

Problem solved

Functional benefit

Products and services

  • Veterinary Domain Testing (TP3)
  • Medical / Industrial / Institutional Domain Testing (PT2-TP4)
  • Healthcare Industries CRO Services
  • Disinfection Equipment Testing
  • Antimicrobial Materials / Textiles Testing

Quantifiable outcome

  • 500 m² of BSL-2 and BSL-3 laboratory space
  • +2 more outcomes

Companies that use VirHealth

Customer profile

Segments5 records

Ideal customer profiles4 records

VirHealth technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature9 records

VirHealth partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor.

  • AnalyzairminorOthersPartner organization displayed on VirHealth's website. Nature of partnership not explicitly defined in available source material.
  • VirnextminorOthersPartner organization displayed on VirHealth's website. Nature of partnership not explicitly defined in available source material.
  • ConidiaminorOthersPartner organization displayed on VirHealth's website. Nature of partnership not explicitly defined in available source material.
  • IzinovationminorOthersPartner organization displayed on VirHealth's website. Nature of partnership not explicitly defined in available source material.
  • VirexprminorOthersPartner organization displayed on VirHealth's website. Nature of partnership not explicitly defined in available source material.
  • France 2030 & Région Auvergne-Rhône-AlpesminorOthersPublic funding initiative and regional government partnership logo displayed on VirHealth's website, indicating potential public funding or regional support for innovation.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

VirHealth competitors and assessment

Company assessment

Broad incumbents

  • NSF International: Global public health and safety organization providing testing, certification, and standards services including antimicrobial product efficacy and disinfectant validation. Direct overlap on regulatory-grade efficacy testing for biocide manufacturers.
  • SGS Société Générale de Surveillance: Global TIC (testing, inspection, certification) giant with a large life sciences and consumer products testing practice covering antimicrobial efficacy, hygiene, and disinfection product validation across PT2-PT4 categories.
  • Eurofins Scientific: Global testing services giant offering microbiological, virological, and disinfection efficacy testing among a massive portfolio. Competes with VirHealth in regulated antimicrobial and biocide testing, especially for large multinational manufacturers.
  • Intertek: Global TIC incumbent with an extensive microbiological and chemical testing network for consumer products, healthcare, and industrial disinfection. Competes on standardized and custom antimicrobial efficacy protocols.
  • bioMérieux: French-headquartered in vitro diagnostics and microbiology leader with industrial microbiology and contract testing services. Adjacent overlap on microbial efficacy and sterility/disinfection testing in pharma and food.

Direct peers

  • Nelson Labs (Sotera Health): Specialized microbiological and sterility testing lab serving medical device, pharmaceutical, and consumer products industries. Overlaps with VirHealth on antimicrobial efficacy, sterilization validation, and cleanroom disinfection testing.
  • Dr. Brill + Partner / Institute for Hygiene and Microbiology: German-based testing institute specializing in disinfectant, antiseptic, and antimicrobial efficacy testing under EN/DVG/VAH standards. Closest continental European peer in standardized biocide testing.
  • Texcell: French-based virology and microbiology CRO offering virus stock production, viral clearance, and biosafety testing. Most direct peer to VirHealth in virology-focused CRO services for healthcare and biocide clients.

Others

  • Laboratoires Anios (Ecolab): Major French disinfectant manufacturer (now part of Ecolab) that commissions and conducts its own antimicrobial testing. Comparable as a customer/ecosystem peer shaping biocide testing protocols in France.

Emerging players

  • Hygiena: Specialty provider of microbial detection and ATP hygiene monitoring, including disinfectant efficacy testing. Closely comparable niche focus on rapid and standard microbiological testing of disinfectants and sanitizers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

VirHealth social profiles

Digital presence

VirHealth compliance and trust

Trust signal

Compliance2 records

VirHealth financial estimates

Financial estimate

Revenue estimate

Valuation estimate

VirHealth leadership team

Management profile

Number of profiles

Profiles1 record

VirHealth funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

VirHealth M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VirHealth

What does VirHealth do?

VirHealth is a specialized Contract Research Organization (CRO) providing antiviral and antimicrobial efficacy testing services for disinfection products, equipment, and technologies. The laboratory operates BSL-2 and BSL-3 facilities in Lyon, France, delivering standardized FR/EN/ISO-compliant efficacy tests, custom protocols, and specialized long-term antimicrobial performance assessments to manufacturers, distributors, and the healthcare and veterinary sectors.

Is VirHealth a public or private company?

VirHealth is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was VirHealth founded?

VirHealth was founded in 2015. It employs 11 to 50 people.

Where is VirHealth based?

VirHealth is headquartered in Lyon, France, in the Europe region.

How does VirHealth make money?

One revenue line is on record: contract Research Organization (CRO) Testing Services.

Who are VirHealth's main competitors?

Broad incumbents on record are NSF International, SGS Société Générale de Surveillance, Eurofins Scientific, Intertek and bioMérieux. Direct peers are Nelson Labs (Sotera Health), Dr. Brill + Partner / Institute for Hygiene and Microbiology and Texcell. Laboratoires Anios (Ecolab) is listed as an others. Hygiena is listed as an emerging player.

Does VirHealth have an API?

No public API is recorded for VirHealth.

What industry is VirHealth in?

VirHealth's product category is Contract Research Laboratory Testing Services. Its primary akta.pro industry code is HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs, with a secondary code of HLAJAIAM, Laboratory Quality Systems, Accreditation & Proficiency Testing Programs. Its NAICS code is 541380 and its SIC code is 8734.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireThe Pure Zone® Protection Film Is 97% Active Against SARS-CoV-2*, The Strain Causing Covid-19*HEXIS Group, a French manufacturer of self-adhesive media, has announced that its PURE ZONE® antimicrobial protection film achieved 97% effectiveness against SARS-CoV-2, 99.8% against HCoV-229E, and 99.9% reduction against common bacterial strains in certified laboratory tests by VirHealth and Eurofins in Lyon. The company manufactures the film at its two factories in southern France and positions it for use on high-touch surfaces in public spaces, medical facilities, and transport. HEXIS executives stated the product aims to provide continuous 24-hour preventative protection to help combat the ongoing pandemic.PR NewswireLe film de protection PURE ZONE® est actif à 97% contre le SARS-CoV-2*, souche responsable de la Covid-19*The HEXIS Group, a French adhesive film manufacturer, announced laboratory-certified test results showing its PURE ZONE® antimicrobial protective film achieves 97% viral reduction on SARS-CoV-2, 99.8% on HCoV-229E, and 99.9% bacterial reduction on common strains including SARM and E. coli. The silver ion-based technology, developed by HEXIS's R&D laboratory since 2013 and tested by VirHealth and Eurofins of Lyon, provides continuous 24-hour surface protection against microbes. HEXIS positions the product as a Made-in-France contribution to fighting the ongoing global pandemic, with the film manufactured at the company's two plants in southern France.